Novel Trispecific Neutralizing Antibodies With Enhanced Potency and Breadth Against Pan‐Sarbecoviruses

ABSTRACT The ongoing emergence of new variants of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) underscores the urgent need for developing antivirals targeting both SARS‐CoV‐2 variants and related sarbecoviruses. To this end, we designed novel trispecific antibodies, Tri‐1 and Tri...

Full description

Bibliographic Details
Published in:	MedComm
Main Authors:	Rui Qiao, Yuanchen Liu, Qiyu Mao, Jiayan Li, Yinying Lu, Jialu Shi, Chen Li, Jizhen Yu, Jiami Gong, Xun Wang, Yuchen Shao, Lei Sun, Wenhong Zhang, Hongjie Yu, Hin Chu, Pengfei Wang, Xiaoyu Zhao
Format:	Article
Language:	English
Published:	Wiley 2025-05-01
Subjects:	coronavirus sarbecovirus SARS‐CoV‐2 bispecific antibody trispecific antibody broadly neutralizing antibody
Online Access:	https://doi.org/10.1002/mco2.70191

Similar Items

Design and Characterization of Bispecific and Trispecific Antibodies Targeting SARS-CoV-2
by: Jiayang Wang, et al.
Published: (2025-02-01)

Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies
by: Antonio Tapia-Galisteo, et al.
Published: (2023-07-01)

Evolving SARS-CoV-2 Vaccines: From Current Solutions to Broad-Spectrum Protection
by: Rui Qiao, et al.
Published: (2025-06-01)

Potent Apoptosis Induction by a Novel Trispecific B7-H3xCD16xTIGIT 2+1 Common Light Chain Natural Killer Cell Engager
by: Michael Ulitzka, et al.
Published: (2024-03-01)

Rapid affinity-based purification of multi-specific antibodies using Kappa Select and Protein L
by: Kalie Mix, et al.
Published: (2025-12-01)

Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer Immunotherapy
by: Zong Sheng Guo, et al.
Published: (2020-07-01)

Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domain
by: Denise Guerra, et al.
Published: (2024-12-01)

Emerging Antibodies in Cancer Therapy
by: Yaping Sun, et al.
Published: (2023-01-01)

Identification and Targeting of Mutant Neoantigens in Multiple Myeloma Treatment
by: Valentina Urzì Brancati, et al.
Published: (2023-04-01)

Rational Design and Characterization of Trispecific Antibodies Targeting the HIV-1 Receptor and Envelope Glycoprotein
by: Jinhu Liang, et al.
Published: (2023-12-01)

Trispecific eFab-eIg T-cell engagers targeting HER2 and HER3
by: Ann-Kathrin Löffler, et al.
Published: (2025-08-01)

Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses
by: Antonio Tapia-Galisteo, et al.
Published: (2024-12-01)

A critical residue in a conserved RBD epitope determines neutralization breadth of pan-sarbecovirus antibodies with recurring YYDRxxG motifs
by: Saskia C. Stein, et al.
Published: (2025-09-01)

A trispecific antibody targeting EGFR/cMET/VEGF-A demonstrates multiple mechanisms of action to inhibit wild-type and mutant NSCLC animal models
by: Ying Jin, et al.
Published: (2025-05-01)

NK Cell-Based Immunotherapy in Colorectal Cancer
by: Mariella Della Chiesa, et al.
Published: (2022-06-01)

Bispecific antibodies provide broad neutralization of emerging beta-coronaviruses by targeting ACE2 and viral spikes
by: Minghui Li, et al.
Published: (2024-12-01)

Trispecific SEED antibodies engineered for neutrophil-mediated cell killing
by: Veronica Natale, et al.
Published: (2025-12-01)

Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity
by: Laura Rubio-Pérez, et al.
Published: (2024-04-01)

Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency
by: Baoshan Zhang, et al.
Published: (2023-12-01)

Broadly Sarbecovirus-Neutralizing Antibodies Induced by Ancestral SARS-CoV-2 Infection
by: Yiwei Zhang, et al.
Published: (2025-09-01)

A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses
by: Bo Feng, et al.
Published: (2025-02-01)

Bispecific antibodies: design, therapy, perspectives
by: Sedykh SE, et al.
Published: (2018-01-01)

Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
by: Jianliang Xu, et al.
Published: (2024-07-01)

Avidity and variable domain spacing strongly influence the therapeutic potency of bispecific antibodies against Crimean-Congo hemorrhagic fever virus
by: Albert Wang, et al.
Published: (2025-05-01)

VERITAS: Harnessing the power of nomenclature in biologic discovery
by: Riti Biswas, et al.
Published: (2023-12-01)

Targeting Herpes Simplex Virus Glycoprotein D with Bispecific Antibodies: Expanding Therapeutic Horizons by Searching for Synergy
by: Doina Atanasiu, et al.
Published: (2025-02-01)

Cancer Immunotherapy by Retargeting of Immune Effector Cells via Recombinant Bispecific Antibody Constructs
by: Slava Stamova, et al.
Published: (2012-07-01)

Lineage switch of adult B-cell acute lymphoblastic leukaemia to acute myeloid leukaemia following B-cell-directed therapy
by: Oscar F. Borja-Montes, et al.
Published: (2025-08-01)

Bispecific antibodies and their use in applied research
by: Harshit Verma, et al.
Published: (2012-01-01)

A Dual-Payload Bispecific ADC Improved Potency and Efficacy over Single-Payload Bispecific ADCs
by: Nicole A. Wilski, et al.
Published: (2025-07-01)

Broadly protective bispecific antibodies that simultaneously target influenza virus hemagglutinin and neuraminidase
by: Kevin E. Ramos, et al.
Published: (2024-07-01)

Bispecific antibody drug conjugates: Making 1+1>2
by: Yilin Gu, et al.
Published: (2024-05-01)

Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
by: Masaud Shah, et al.
Published: (2025-01-01)

Topological Scaffold‐Based Trispecific Recombinant Protein‐Drug Conjugates for Solid Tumor Eradication
by: Huiyi Jiang, et al.
Published: (2025-10-01)

Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
by: Gihoon You, et al.
Published: (2021-07-01)

Improving dual targeting selectivity in T-cell engagers via synapse-gated and affinity-tuned trispecific antibody design
by: Peng Zhao, et al.
Published: (2025-12-01)

Modified Therapeutic Antibodies: Improving Efficacy
by: Ji-Min Dai, et al.
Published: (2021-11-01)

Advances in Emerging Therapies for Multiple Myeloma
by: QIAN Chenjing, et al.
Published: (2023-03-01)

Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2
by: Nan Gao, et al.
Published: (2022-05-01)

A novel bispecific antibody targeting two overlapping epitopes in RBD improves neutralizing potency and breadth against SARS-CoV-2
by: Hancong Sun, et al.
Published: (2024-12-01)